The Expanding MASH Market: How Rezdiffra, Wegovy Might Coexist

 
• By Joseph Haas
  
Fatty liver disease
The MASH market will take a turn in the US with a second FDA-approved drug • Source: Shutterstock

More from Strategy

More from Business